| Literature DB >> 26431953 |
Abstract
This article presents the spectrum of indications for the use of hyaluronic acid (HA) based on the recommendations of the European League Against Rheumatism (EULAR), the American College of Rheumatology (ACR), the Osteoarthritis Research Society International (OARSI), the International Institute for Health and Clinical Excellence (NICE) and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) taking the reality of patient care in Europe into account.Entities:
Keywords: Arthritis; Indications; Management; Recommendations; Treatment
Mesh:
Substances:
Year: 2015 PMID: 26431953 DOI: 10.1007/s00393-015-1625-y
Source DB: PubMed Journal: Z Rheumatol ISSN: 0340-1855 Impact factor: 1.372